SCHEMBL29192556

SCHEMBL29192556

COc1cc(C(F)(F)F)ncc1I

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.40
CHEK1 O14757 1/20 0.34
TRPV4 Q9HBA0 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
CA2 P00918 1/20 0.33
CHKA P35790 1/20 0.33
P2RX3 P56373 4/20 0.33
P2RX2 Q9UBL9 4/20 0.33
AURKA O14965 2/20 0.33
KDR P35968 2/20 0.33
AURKB Q96GD4 2/20 0.33
ALDH1A1 P00352 1/20 0.32
HCRTR1 O43613 1/20 0.32
LMNA P02545 2/20 0.32
HPGD P15428 2/20 0.32
HTT P42858 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
HSD17B10 Q99714 2/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30358920 1.00 PDE10A (0.40) PDE10ACHEK1TRPV4SMN1; SMN2TSHR
SCHEMBL929688 0.85 PDE10A (0.40) PDE10ACHEK1TRPV4SMN1; SMN2TSHR
SCHEMBL30018060 0.85 PDE10A (0.40) PDE10ACHEK1TRPV4SMN1; SMN2TSHR
SCHEMBL14183066 0.79 PDE10A (0.40) PDE10ACHEK1TRPV4SMN1; SMN2TSHR
SCHEMBL31045864 0.78 PDE10A (0.43) PDE10ACHEK1TRPV4SMN1; SMN2TSHR
SCHEMBL17949359 0.76 TRPV4 (0.41) TRPV4CA2CHKA
SCHEMBL22161741 0.76 PDE10A (0.40) PDE10ACHEK1TRPV4SMN1; SMN2TSHR
SCHEMBL30868926 0.75 PDE10A (0.41) PDE10ACHEK1TRPV4SMN1; SMN2TSHR
SCHEMBL7919171 0.75 PDE10A (0.38) PDE10ACHEK1TRPV4SMN1; SMN2TSHR
SCHEMBL1506552 0.75 TRPV4 (0.38) TRPV4CA2CHKAALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117651699-A Compounds and compositions for the treatment of coronavirus related diseases 诺华股份有限公司 2024-03-05 CN disclosed